Oxycodone does not affect placental circulatory physiology during the early first stage of labor—A randomized trial

Abstract Introduction Opioids are used for pain relief during the first stage of labor. Oxycodone can cause maternal hypotension that may modify utero‐ and fetoplacental circulatory physiology. We hypothesized that maternal intravenous (i.v.) oxycodone has no detrimental effect on utero‐ and fetopla...

Full description

Saved in:
Bibliographic Details
Main Authors: Leena Alanne, Hannu Kokki, Anu Mykkänen, Maija‐Riitta Ordén, Valtteri Rinne, Juha Räsänen, Merja Kokki
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:Acta Obstetricia et Gynecologica Scandinavica
Subjects:
Online Access:https://doi.org/10.1111/aogs.14603
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849687268654055424
author Leena Alanne
Hannu Kokki
Anu Mykkänen
Maija‐Riitta Ordén
Valtteri Rinne
Juha Räsänen
Merja Kokki
author_facet Leena Alanne
Hannu Kokki
Anu Mykkänen
Maija‐Riitta Ordén
Valtteri Rinne
Juha Räsänen
Merja Kokki
author_sort Leena Alanne
collection DOAJ
description Abstract Introduction Opioids are used for pain relief during the first stage of labor. Oxycodone can cause maternal hypotension that may modify utero‐ and fetoplacental circulatory physiology. We hypothesized that maternal intravenous (i.v.) oxycodone has no detrimental effect on utero‐ and fetoplacental hemodynamics during the early first stage of labor. Material and methods Twenty‐two parturients requiring pain relief during the first stage of labor were randomized in a double‐blinded and placebo‐controlled study. By Doppler ultrasonography, both uterine artery (Ut) and umbilical vein (UV) volume blood flows (Q), Ut pulsatility index (PI), and Ut vascular resistance (RUt) were calculated. Blood flow velocity waveforms were obtained between uterine contractions. After baseline measurements, women received oxycodone 0.05 mg/kg or a placebo intravenous. Doppler ultrasonography was repeated up to 120 min after the first drug administration. The second dose of oxycodone 0.05 mg/kg was allowed at 60 min to all parturients with contraction pain ≥5/10. Maternal plasma samples were collected at each study phase and after delivery with umbilical cord plasma samples, to measure oxycodone concentrations. ClinicalTrials.gov identifier (NCT no. NCT02573831). Results At baseline, mean QUt and QUV did not differ significantly between the placebo‐first (478 mL/min and 57 mL/min/kg) and the oxycodone‐first (561 mL/min and 71 mL/min/kg) groups. In addition, RUt and Ut PI were comparable between the groups. Following oxycodone at 60 min, mean QUt and QUV (714 mL/min and 52 mL/min/kg) were similar to the placebo‐first (520 mL/min and 55 mL/min/kg) group. Furthermore, all the measured parameters were comparable to the baseline values. At 60 min after the first study drug administration, all the parturients in the placebo‐first group needed intravenous oxycodone 0.05 mg/kg. At 120 min, we found no statistically significant change in any of the measured parameters. No significant correlation was found between maternal oxycodone concentration and QUt or QUV. Furthermore, newborn oxycodone concentration did not correlate with QUV. Conclusions Oxycodone did not have any detrimental effect on either utero‐ or fetoplacental circulatory physiology during the early first stage of labor. Maternal plasma oxycodone did not correlate with utero‐ and fetoplacental hemodynamics. No correlation was found between newborn oxycodone concentration and fetoplacental hemodynamics.
format Article
id doaj-art-96684d920cd4450cb50f2235552014f5
institution DOAJ
issn 0001-6349
1600-0412
language English
publishDate 2023-08-01
publisher Wiley
record_format Article
series Acta Obstetricia et Gynecologica Scandinavica
spelling doaj-art-96684d920cd4450cb50f2235552014f52025-08-20T03:22:22ZengWileyActa Obstetricia et Gynecologica Scandinavica0001-63491600-04122023-08-0110281063107210.1111/aogs.14603Oxycodone does not affect placental circulatory physiology during the early first stage of labor—A randomized trialLeena Alanne0Hannu Kokki1Anu Mykkänen2Maija‐Riitta Ordén3Valtteri Rinne4Juha Räsänen5Merja Kokki6Department of Obstetrics and Gynecology Kuopio University Hospital Kuopio FinlandSchool of Medicine University of Eastern Finland Kuopio FinlandDepartment of Obstetrics and Gynecology Kuopio University Hospital Kuopio FinlandDepartment of Obstetrics and Gynecology Kuopio University Hospital Kuopio FinlandAdmescope Ltd Oulu FinlandFetal Medicine Center, Department of Obstetrics and Gynecology Helsinki University Hospital and University of Helsinki Helsinki FinlandAnesthesiology and Intensive Care Kuopio University Hospital Kuopio FinlandAbstract Introduction Opioids are used for pain relief during the first stage of labor. Oxycodone can cause maternal hypotension that may modify utero‐ and fetoplacental circulatory physiology. We hypothesized that maternal intravenous (i.v.) oxycodone has no detrimental effect on utero‐ and fetoplacental hemodynamics during the early first stage of labor. Material and methods Twenty‐two parturients requiring pain relief during the first stage of labor were randomized in a double‐blinded and placebo‐controlled study. By Doppler ultrasonography, both uterine artery (Ut) and umbilical vein (UV) volume blood flows (Q), Ut pulsatility index (PI), and Ut vascular resistance (RUt) were calculated. Blood flow velocity waveforms were obtained between uterine contractions. After baseline measurements, women received oxycodone 0.05 mg/kg or a placebo intravenous. Doppler ultrasonography was repeated up to 120 min after the first drug administration. The second dose of oxycodone 0.05 mg/kg was allowed at 60 min to all parturients with contraction pain ≥5/10. Maternal plasma samples were collected at each study phase and after delivery with umbilical cord plasma samples, to measure oxycodone concentrations. ClinicalTrials.gov identifier (NCT no. NCT02573831). Results At baseline, mean QUt and QUV did not differ significantly between the placebo‐first (478 mL/min and 57 mL/min/kg) and the oxycodone‐first (561 mL/min and 71 mL/min/kg) groups. In addition, RUt and Ut PI were comparable between the groups. Following oxycodone at 60 min, mean QUt and QUV (714 mL/min and 52 mL/min/kg) were similar to the placebo‐first (520 mL/min and 55 mL/min/kg) group. Furthermore, all the measured parameters were comparable to the baseline values. At 60 min after the first study drug administration, all the parturients in the placebo‐first group needed intravenous oxycodone 0.05 mg/kg. At 120 min, we found no statistically significant change in any of the measured parameters. No significant correlation was found between maternal oxycodone concentration and QUt or QUV. Furthermore, newborn oxycodone concentration did not correlate with QUV. Conclusions Oxycodone did not have any detrimental effect on either utero‐ or fetoplacental circulatory physiology during the early first stage of labor. Maternal plasma oxycodone did not correlate with utero‐ and fetoplacental hemodynamics. No correlation was found between newborn oxycodone concentration and fetoplacental hemodynamics.https://doi.org/10.1111/aogs.14603circulationexposurefetuslabornewbornoxycodone
spellingShingle Leena Alanne
Hannu Kokki
Anu Mykkänen
Maija‐Riitta Ordén
Valtteri Rinne
Juha Räsänen
Merja Kokki
Oxycodone does not affect placental circulatory physiology during the early first stage of labor—A randomized trial
Acta Obstetricia et Gynecologica Scandinavica
circulation
exposure
fetus
labor
newborn
oxycodone
title Oxycodone does not affect placental circulatory physiology during the early first stage of labor—A randomized trial
title_full Oxycodone does not affect placental circulatory physiology during the early first stage of labor—A randomized trial
title_fullStr Oxycodone does not affect placental circulatory physiology during the early first stage of labor—A randomized trial
title_full_unstemmed Oxycodone does not affect placental circulatory physiology during the early first stage of labor—A randomized trial
title_short Oxycodone does not affect placental circulatory physiology during the early first stage of labor—A randomized trial
title_sort oxycodone does not affect placental circulatory physiology during the early first stage of labor a randomized trial
topic circulation
exposure
fetus
labor
newborn
oxycodone
url https://doi.org/10.1111/aogs.14603
work_keys_str_mv AT leenaalanne oxycodonedoesnotaffectplacentalcirculatoryphysiologyduringtheearlyfirststageoflaborarandomizedtrial
AT hannukokki oxycodonedoesnotaffectplacentalcirculatoryphysiologyduringtheearlyfirststageoflaborarandomizedtrial
AT anumykkanen oxycodonedoesnotaffectplacentalcirculatoryphysiologyduringtheearlyfirststageoflaborarandomizedtrial
AT maijariittaorden oxycodonedoesnotaffectplacentalcirculatoryphysiologyduringtheearlyfirststageoflaborarandomizedtrial
AT valtteririnne oxycodonedoesnotaffectplacentalcirculatoryphysiologyduringtheearlyfirststageoflaborarandomizedtrial
AT juharasanen oxycodonedoesnotaffectplacentalcirculatoryphysiologyduringtheearlyfirststageoflaborarandomizedtrial
AT merjakokki oxycodonedoesnotaffectplacentalcirculatoryphysiologyduringtheearlyfirststageoflaborarandomizedtrial